1The Diabetes Control and Complications Trial ResearchGroup. The effect of intensive treatment of diabetes on thedevelopment and progression of long-term complications ininsulin-dependent diabetes mellitus. The Diabetes Control andComplications Trial Research Group. N Engl J Med 1993; 329:977-986 [PMID: 8366922 DOI: 10.1056/NEJM199309303291401].
2UK Prospective Diabetes Study (UKPDS) Group. Intensiveblood-glucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications inpatients with type 2 diabetes (UKPDS 33). UK ProspectiveDiabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853 [PMID:9742976 DOI: 10.1016/S0140-6736(98)07019-6].
3Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N,Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, WarrenSR, Goldman S, McCarren M, Vitek ME, Henderson WG,Huang GD. Glucose control and vascular complications inveterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139[PMID: 19092145 DOI: 10.1056/NEJMoa0808431].
5Patel A, MacMahon S, Chalmers J, Neal B, Billot L, WoodwardM, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P,Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C,Poulter N, Rodgers A, Williams B, Bompoint S, de GalanBE, Joshi R, Travert F. Intensive blood glucose control andvascular outcomes in patients with type 2 diabetes. N EnglJ Med 2008; 358: 2560-2572 [PMID: 18539916 DOI: 10.1056/NEJMoa0802987].
6Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP,Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B,Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, SivitzWI, Speril-Hillen JM, Sweeney ME. The association betweensymptomatic, severe hypoglycaemia and mortality in type2 diabetes: retrospective epidemiological analysis of theACCORD study. BMJ 2010; 340: b4909 [PMID: 20061358 DOI:10.1136/bmj.b4909].
